Filippo Pietrantonio

Filippo Pietrantonio

UNVERIFIED PROFILE

Are you Filippo Pietrantonio?   Register this Author

Register author
Filippo Pietrantonio

Filippo Pietrantonio

Publications by authors named "Filippo Pietrantonio"

Are you Filippo Pietrantonio?   Register this Author

100Publications

3173Reads

14Profile Views

Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.

Clin Colorectal Cancer 2019 Jun 7;18(2):116-124. Epub 2019 Mar 7.

Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2019.02.007DOI Listing
June 2019

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.

Clin Colorectal Cancer 2019 Jun 1;18(2):e179-e190. Epub 2019 Apr 1.

Medical Oncology Department, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2019.03.002DOI Listing
June 2019

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.

Cell Metab 2018 12 30;28(6):848-865.e6. Epub 2018 Aug 30.

Candiolo Cancer Institute - FPO, IRCCS, Strada Provinciale 142, Torino, Candiolo 10060, Italy; University of Torino, Department of Oncology, 10060, Torino, Candiolo, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15504131183050
Publisher Site
http://dx.doi.org/10.1016/j.cmet.2018.08.006DOI Listing
December 2018

Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.

Pharmacogenomics 2018 08 25;19(13):1047-1068. Epub 2018 Jul 25.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0077DOI Listing
August 2018

Bright-field in situ hybridization detects gene alterations and viral infections useful for personalized management of cancer patients.

Expert Rev Mol Diagn 2018 03 21;18(3):259-277. Epub 2018 Feb 21.

a Department of Pathology and Laboratory Medicine , Fondazione IRCCS, Istituto Nazionale dei Tumori , Milano , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2018.1440210DOI Listing
March 2018

Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer.

Eur J Cancer 2017 11 6;86:197-206. Epub 2017 Oct 6.

Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Los Angeles, CA 90033, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.033DOI Listing
November 2017

Prognostic factors after R0 resection of colorectal cancer liver metastases: A systematic review and pooled-analysis.

Rev Recent Clin Trials 2016 ;11(1):56-62

Medical Oncology Unit, Oncology Department, Azienda Ospedaliera Treviglio, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy.

View Article

Download full-text PDF

Source
December 2016

How the lab is changing our view of colorectal cancer.

Tumori 2016 Dec 20;102(6):541-547. Epub 2016 Sep 20.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000551DOI Listing
December 2016

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.

Ann Surg Oncol 2016 12 28;23(13):4222-4230. Epub 2016 Jun 28.

Peritoneal Malicnancy Program, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5350-9DOI Listing
December 2016

Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.

Cancer Discov 2016 12 21;6(12):1315-1333. Epub 2016 Nov 21.

Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140697PMC
December 2016

Impact on survival of timing and duration of adjuvant chemotherapy in radically resected gastric cancer.

Tumori 2016 Aug 3;102(4):e15-9. Epub 2016 Aug 3.

Istituto di Ricerche Farmacologiche "Mario Negri," Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000480DOI Listing
August 2016

Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.

Gastric Cancer 2016 Apr 11;19(2):412-420. Epub 2015 Apr 11.

Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0495-yDOI Listing
April 2016

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review.

Crit Rev Oncol Hematol 2016 Apr 22;100:209-22. Epub 2016 Jan 22.

Peritoneal Malignancy Program, Fondazione IRCCS Istituto Nazionale Tumori, via Venezian, 1 20133 Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.01.017DOI Listing
April 2016

Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials.

Crit Rev Oncol Hematol 2016 Feb 9;98:24-8. Epub 2015 Oct 9.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.09.002DOI Listing
February 2016

BRAF-mutated metastatic colorectal cancer between past and future.

Br J Cancer 2015 Dec 10;113(11):1634-5. Epub 2015 Sep 10.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705874PMC
December 2015

BRAF in metastatic colorectal cancer: the future starts now.

Pharmacogenomics 2015 Dec 30;16(18):2069-81. Epub 2015 Nov 30.

Medical Oncology Department, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.140DOI Listing
December 2015

First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis.

Crit Rev Oncol Hematol 2015 Oct 5;96(1):156-66. Epub 2015 Jun 5.

Fondazione IRCCS Istituto Nazionale dei Tumori, Medical Oncology Unit, Milan, Italy; Department of Radiology, Oncology and Human-Pathology, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.05.016DOI Listing
October 2015

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer.

Clin Interv Aging 2015 5;10:127-33. Epub 2015 Jan 5.

Department of Medical Oncology, Sacro Cuore-Don Calabria Hospital, Negrar, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CIA.S54675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289484PMC
September 2015

Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians.

Crit Rev Oncol Hematol 2015 Sep 25;95(3):272-81. Epub 2015 Apr 25.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.04.008DOI Listing
September 2015

LightSNiP assay is a good strategy for pharmacogenetics test.

Front Pharmacol 2015 2;6:114. Epub 2015 Jun 2.

Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences L. Sacco, "Luigi Sacco" University Hospital, Università di Milano Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2015.00114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451335PMC
June 2015

Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: a systematic review and pooled-analysis.

Eur J Cancer 2015 May 17;51(7):800-7. Epub 2015 Mar 17.

Department of Oncology, Medical Oncology Unit, Azienda Ospedaliera Treviglio, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy. Electronic address:

View Article

Download full-text PDF

Source
http://www.researchgate.net/profile/Fausto_Petrelli2/publica
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S095980491500211
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2015.02.011DOI Listing
May 2015

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.

Eur J Cancer 2015 Mar 9;51(5):587-94. Epub 2015 Feb 9.

Department of Oncology, Medical Oncology Unit, Azienda Ospedaliera Treviglio, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.01.054DOI Listing
March 2015

In reply.

Oncologist 2015 Mar;20(3):e5

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-423DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350808PMC
March 2015

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials.

Br J Clin Pharmacol 2014 Dec;78(6):1228-37

Department of Meical Oncology, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy; PhD Program, Department of Radiology Oncology and Human Pathology, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256612PMC
December 2014

FOLFIRI with cetuximab or bevacizumab: FIRE-3.

Lancet Oncol 2014 Dec 24;15(13):e581. Epub 2014 Nov 24.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70397-3DOI Listing
December 2014

Role of MGMT as biomarker in colorectal cancer.

World J Clin Cases 2014 Dec;2(12):835-9

Alessandro Inno, Stefania Gori, Massimo Cirillo, Medical Oncology Department, Ospedale Sacro Cuore Don Calabria, Negrar, 37100 Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12998/wjcc.v2.i12.835DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266830PMC
December 2014

TP53 mutations in advanced colorectal cancer: the dark side of the moon.

Oncology 2014 7;86(5-6):289-94. Epub 2014 Jun 7.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori (National Cancer Institute), Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360088DOI Listing
September 2014

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.

Oncologist 2014 Aug 20;19(8):845-50. Epub 2014 Jun 20.

Medical Oncology Department, Surgery Department, Pathology and Molecular Biology Department, Scientific Directorate, and Clinical Nutrition Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122474PMC
August 2014

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

World J Gastroenterol 2014 Apr;20(16):4516-25

Rosalba Miceli, Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i16.4516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000488PMC
April 2014